Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CMLF

CM Life Sciences (CMLF)

CM Life Sciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CMLF
FechaHoraFuenteTítuloSímboloCompañía
21/06/202315:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMLFCM Life Sciences Inc
20/06/202316:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMLFCM Life Sciences Inc
09/06/202315:16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMLFCM Life Sciences Inc
25/04/202316:25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CMLFCM Life Sciences Inc
20/04/202315:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMLFCM Life Sciences Inc
10/02/202315:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CMLFCM Life Sciences Inc
01/02/202316:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CMLFCM Life Sciences Inc
30/01/202316:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CMLFCM Life Sciences Inc
08/09/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CMLFCM Life Sciences Inc
07/09/202216:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CMLFCM Life Sciences Inc
26/08/202215:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CMLFCM Life Sciences Inc
15/08/202215:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMLFCM Life Sciences Inc
06/05/202218:18Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CMLFCM Life Sciences Inc
31/03/202216:18Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:CMLFCM Life Sciences Inc
14/03/202216:11Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:CMLFCM Life Sciences Inc
14/03/202215:34Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CMLFCM Life Sciences Inc
14/03/202205:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CMLFCM Life Sciences Inc
13/10/202113:32Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMLFCM Life Sciences Inc
16/08/202116:19Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CMLFCM Life Sciences Inc
22/07/202108:15GlobeNewswire Inc.Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform CompanyNASDAQ:CMLFCM Life Sciences Inc
07/07/202106:00Business WireFormer Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of DirectorsNASDAQ:CMLFCM Life Sciences Inc
02/07/202111:15Business WireCM Life Sciences & Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Bus. Combi...NASDAQ:CMLFCM Life Sciences Inc
28/06/202115:22Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CMLFCM Life Sciences Inc
17/06/202106:00Business WireSema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data OfficerNASDAQ:CMLFCM Life Sciences Inc
10/06/202116:12Business WireSema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy StatementNASDAQ:CMLFCM Life Sciences Inc
25/05/202106:00Business WireAdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and OutcomesNASDAQ:CMLFCM Life Sciences Inc
24/05/202106:00Business WireSema4 to Participate in Upcoming Investor ConferencesNASDAQ:CMLFCM Life Sciences Inc
18/05/202112:29Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CMLFCM Life Sciences Inc
06/05/202116:31Business WireSema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed MergerNASDAQ:CMLFCM Life Sciences Inc
05/05/202105:10Business WireCM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Ac...NASDAQ:CMLFCM Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:CMLF